Kontigo Care Q1 2023: Initial take - Redeye

Redeye concludes that Kontigo Care’s Q1’23 report was slightly weaker than expected. However, we see no major drama as business activity remains high, and the anticipated price increases are expected to offset higher costs. Consequently, we anticipate only minor adjustments to our fair value range and estimates.

Länk till analysen i sin helhet: https://www.redeye.se/research/907588/kontigo-care-q1-2023-initial-take?utm_source=finwire&utm_medium=RSS